+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Impact of polyphenols on receptor-ligand interactions by NMR: the case of neurotensin (NT)-neurotensin receptor fragment (NTS1) complex



Impact of polyphenols on receptor-ligand interactions by NMR: the case of neurotensin (NT)-neurotensin receptor fragment (NTS1) complex



Journal of Biomolecular Structure and Dynamics 2019: 1-12



Ligand-receptor interactions can be implicated in many pathological events such as chronic neurodegenerative diseases. Thus, the discovery of molecules disrupting this type of interactions could be an interesting therapeutic approach. Polyphenols are well known for their affinity for proteins and several studies have characterized these direct interactions. But studying the direct influence of multi-therapeutic drugs on a ligand-receptor complex relevant to a neurodegenerative disorder is a challenging issue. Solution NMR, molecular modeling and iterative calculations were used to obtain information about the interaction between a phenolic compound, α-glucogallin (α-2) and a ligand/fragment receptor complex neurotensin (NT) and its receptor NTS1. The α-2 was shown to bind to NT and a peptidic fragment of its NTS1 receptor, independently. Although the formation of the corresponding ligand-receptor complex did not seem to be affected, this experimental modeling protocol will enable the evaluation of other anti-amyloidogenic compounds such as blockers of NT-NTS1 binding. These types of studies help in understanding the specificity and influence in binding and can provide information to develop new molecules with a putative pharmacological interest. Communicated by Ramaswamy H. Sarma.

(PDF emailed within 0-6 h: $19.90)

Accession: 066746197

Download citation: RISBibTeXText

PMID: 31046599

DOI: 10.1080/07391102.2019.1608863


Related references

Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders. Current Medicinal Chemistry 19(3): 304-316, 2012

Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis. Peptides 28(10): 2030-2035, 2007

Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia. Current Protein and Peptide Science 15(7): 681-690, 2015

Neurotensin modulates central muscarinic receptors, an effect which does not involve the high-affinity neurotensin receptor (NTS1). Regulatory Peptides 163(1-3): 37-42, 2011

The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach. Bioorganic and Medicinal Chemistry Letters 18(21): 5789-5791, 2008

The Neurotensin NTS 1 Receptor Agonist PD149163 Produces Antidepressant-Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant Drugs. Drug Development Research 78(5): 196-202, 2017

Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics. Acs Chemical Neuroscience 2(6): 308-316, 2012

Effect of the neurotensin receptor antagonist SR48692 on the expression of neurotensin and neurotensin receptor mRNA in rat brain. Society for Neuroscience Abstracts 19(1-3): 1184, 1993

Thermostabilization of the neurotensin receptor NTS1. Journal of Molecular Biology 390(2): 262-277, 2009

Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: Agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor. Neuroscience Letters 223(3): 193-196, 1997

Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus. Molecular Pharmacology 64(2): 421-429, 2003

Functional domains of the subtype 1 neurotensin receptor (NTS1). Peptides 27(10): 2461-2468, 2006

Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor. Journal of Biomolecular Structure and Dynamics 31(12): 1381-1392, 2014

Evidence for additional neurotensin receptor subtypes: Neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception. Brain Research 792(2): 246-252, 1998

Microdialysis studies with intrastriatal neurotensin 1-13 and neurotensin 8-13 on striatal GABA and dopamine release in the awake rat evidence for neurotensin receptor heterogeneity in the neostriatum. Society for Neuroscience Abstracts 22(1-3): 76, 1996